Hereditary Canine Spinal Muscular Atrophy: An Animal Model of Motor Neuron Disease

ABSTRACT: Motor neuron diseases selectively produce degeneration and death of motor neurons; the pathogenesis of these disorders and the specificity for this population of neurons are unknown. Hereditary Canine Spinal Muscular Atrophy produces a lower motor neuron disease which is clinically and pathologically similar to human motor neuron disease: motor neurons dysfunction and degenerate. The canine model provides an opportunity to investigate early stages of disease when there are viable motor neurons still present and might be responsive to a variety of therapeutic interventions. The canine disease, like the human disease, is inherited as an autosomal dominant. The extensive canine pedigree of more than 200 characterized individuals permits genetic analysis using syntenic linkage techniques which may identify a marker for the canine trait and provide insights into homologous regions for study in human kindreds.

[1]  A. Plaitakis Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: A hypothesis , 1990, Annals of neurology.

[2]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[3]  A. Eisen,et al.  Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid , 1990, Annals of neurology.

[4]  T. Lehner,et al.  Genetic homogeneity between acute and chronic forms of spinal muscular atrophy , 1990, Nature.

[5]  M. Lathrop,et al.  Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q , 1990, Nature.

[6]  M. Leppert,et al.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3 , 1990, Nature.

[7]  D. Price,et al.  Changes in size of motor axons in hereditary canine spinal muscular atrophy. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[8]  D. Price,et al.  Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[9]  L. Olson,et al.  Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons , 1989, Neuron.

[10]  T. Perry,et al.  Brain glutamate deficiency in amyotrophic lateral sclerosis , 1987, Neurology.

[11]  F. Hefti,et al.  Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  W. Bradley,et al.  Amyotrophic leteral sclerosis: Part 2. Etiopathogenesis , 1985 .

[13]  D. Price,et al.  Autosomal dominant inheritance of hereditary canine spinal muscular atrophy , 1984, Annals of neurology.

[14]  L. Rowland Motor neuron diseases and amyotrophic lateral sclerosis , 1984, Trends in Neurosciences.

[15]  S. Carpenter,et al.  Neurofibrillary axonal swellings and amyotrophic lateral sclerosis , 1984, Journal of the Neurological Sciences.

[16]  D. Price,et al.  AXONAL TRANSPORT IN HEREDITARY CANINE SPINAL MUSCULAR ATROPHY (HCSMA): 88 , 1982 .

[17]  D. Price,et al.  THE TRANSPORT OF ACTIN AND TUBULIN AND THE RATE OF AXONAL REGENERATION: 89 , 1982 .

[18]  D. Price,et al.  Pathology of motor neurons in accelerated hereditary canine spinal muscular atrophy. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[19]  D. Price,et al.  Hereditary spinal muscular atrophy in Brittany Spaniels: clinical manifestations. , 1979, Journal of the American Veterinary Medical Association.

[20]  D. Price,et al.  HEREDITARY CANINE SPINAL MUSCULAR ATROPHY , 1979, Journal of neuropathology and experimental neurology.

[21]  S. Carpenter Proximal axonal enlargement in motor neuron disease , 1968, Neurology.